Twist Bioscience CorporationTWSTNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank60
3Y CAGR-10.7%
5Y CAGR+2.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-10.7%/yr
vs +31.6%/yr prior
5Y CAGR
+2.0%/yr
Recent deceleration
Acceleration
-42.3pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
4 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$76.11M-5.2%
2025$80.28M-11.6%
2024$90.85M-15.0%
2023$106.89M-11.1%
2022$120.31M+74.2%
2021$69.07M+60.6%
2020$43.01M+20.5%
2019$35.68M+75.4%
2018$20.35M+6.1%
2017$19.17M-